ARCHIVES

MDV3100 Improves Survival, Reduces Death Risk by 37%

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

“One Time Offer” On Comprehensiveness Approved By NCAB

September 22, 1989

In Brief: Sparano Named Vice Chair of ECOG-ACRIN

May 17, 2013

In Breif: Folkman selected For Karnofsky Lecture; Sporn to give ACS Lecture At ASCO

February 2, 1996

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

Prevention & Control Study Section In DRG Requested By NCI

February 8, 1991